Online Inquiry
B4GALNT2 Knockout Cell Line
SPL-00603
Size | Price |
1 Unit | Online Inquiry |
Description |
---|
11bp deletion |
Target Information | |
---|---|
Target Name | B4GALNT2 |
Gene Abbr. | B4GALNT2 |
Gene ID | 124872 |
Full Name | beta-1,4-N-acetyl-galactosaminyltransferase 2 |
Alias | B4GALT, GALGT2 |
Species | Human |
Genomic Locus | chr17:49141399 |
Transcript | NM_001159388 |
WT Expression Level | 4.70 TPM (TPM = Transcripts per million; any value less than 3 is considered non-expressing) |
Introduction | B4GALNT2 catalyzes the last step in the biosynthesis of the human Sd(a) antigen through the addition of an N-acetylgalactosamine residue via a beta-1,4 linkage to a subterminal galactose residue substituted with an alpha-2,3-linked sialic acid. B4GALNT2 also catalyzes the last step in the biosynthesis of the Cad antigen (Montiel et al., 2003 [PubMed 12678917]).[supplied by OMIM, Mar 2008]. |
Product Details | |
---|---|
Cell Line Model | HAP1 |
Genotype | HAP1 cell line, edited by CRISPR/Cas to contain a 11bp deletion in a coding exon of B4GALNT2. |
Description | 11bp deletion |
Parental Cell Line | C631 |
Guide RNA Sequence | TTCTGCCTGAGGAACGTCTC |
PCR Primer |
Forward: GTGGCTCCTCAAGATATTGGTCATA Reverse: GGGATTTTGCTGGATGCTATAGAGA |
Handling Specifications | |
---|---|
Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into 10 mL of pre-warmed media in a 10 cm dish. |
Culture Medium | IMDM + 10% FCS |
Growth Properties | Cells are adherent cells that are cultured at 37°C in a humidified atmosphere with 5% CO2. Cells should be passaged every 2-3 days, splitting approximately 1:10-1:20. |
Freeze Medium | IMDM + 20% FCS + 10% DMSO |
Biosafety Level | BSL-1 |
Disclaimer | This product is classified under IATA regulations as a GMMO (genetically modified micro-organism) and will ship as UN3245. If applicable, ensure facility meets all requirements per local and country regulations. |
For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.